Glazer Capital’s Frazier Lifesciences Acquisition Corp Warrant FLACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-36,150
Closed -$6K – 843
2022
Q1
$6K Sell
36,150
-7,814
-18% -$3.4K ﹤0.01% 537
2021
Q4
$26K Buy
+43,964
New +$30.7K ﹤0.01% 768

Other funds holding FLACW

Glazer Capital's FLACW Position: Q2 2022 in Review

Glazer Capital sold out of Frazier Lifesciences Acquisition Corp Warrant (FLACW) in Q2 2022, closing a stake of 36,150 shares — an estimated $6K sold.

Glazer Capital first reported a position in FLACW in Q4 2021 and held it in 2 quarters. The position peaked at $26K in Q4 2021. 30 funds tracked by Wall St. Rank hold FLACW as of Q2 2022.

  • Glazer Capital reported no remaining Frazier Lifesciences Acquisition Corp Warrant position as of Q2 2022 after selling out during the quarter.
  • Glazer Capital sold 36,150 Frazier Lifesciences Acquisition Corp Warrant shares in Q2 2022, an estimated $6K.
  • Glazer Capital first reported a position in Frazier Lifesciences Acquisition Corp Warrant in Q4 2021 and held it in 2 quarters.
  • Glazer Capital's Frazier Lifesciences Acquisition Corp Warrant position peaked at $26K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corp Warrant as of Q2 2022.

Based on Glazer Capital's 13F filing for Q2 2022, filed 15 Aug 2022.